Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year.

@article{Barragan2008ElectiveIO,
  title={Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year.},
  author={Paul Barragan and Jean Fajadet and Imad Sheiban and Patrick A Serruys and Antonio Colombo and Ricardo Seabra-Gomes and J. J. Goy and St{\'e}phane Cook and Paolo Rubino and Thierry Lefevre},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2008},
  volume={4 2},
  pages={
          262-70
        }
}
  • Paul Barragan, Jean Fajadet, +7 authors Thierry Lefevre
  • Published in
    EuroIntervention : journal of…
    2008
  • Medicine
  • AIMS Recent studies of drug-eluting stents for unprotected left main coronary artery (LMCA) disease have been encouraging. We examined the performance of sirolimus-eluting stents (SES) for this indication. METHODS AND RESULTS This retrospective study included 228 consecutive patients (mean age = 68 +/- 11 years, 80.6% men, 26.3% diabetics) who underwent implantation of SES for de novo LMCA stenoses. The mean additive and logistic EuroSCOREs were 5.2 +/- 3.9 and 8.2 +/- 13.2, respectively. The… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv